Clinical Trials in Phoenix

Showing 5581-5600 of 12,606 trials

COMPLETEDPhase 1< 1 mile

Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects

NCT04802863

This is a Phase 1, open-label, single-center study of XNW4107 and imipenem/cilastatin administered intravenously.

Bacterial Infections

Evopoint Biosciences Inc.21 participantsStarted Mar 2021

Phoenix, Arizona, United States

COMPLETEDPhase 3< 1 mile

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

NCT01963208

The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic medications (AEDs).

Drug Resistant Partial Onset Seizure

Marinus Pharmaceuticals405 participantsStarted Oct 2013

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +68 more locations

Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Find Trials by Condition in Phoenix

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Clostridium Difficile Vaccine Efficacy Trial

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Safety and Efficacy in Adult Subjects With Acute Migraines

Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis

Trial in Adult Subjects With Acute Migraines

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection

A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Web-based Implementation for the Science of Enhancing Resilience Study

Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

Evaluating an Emergency Department Observation Syncope Protocol for Older Adults

Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System